However, our previous work showed that <5% of Tie2+ cells expressed myeloid marker CD11b or pericyte marker NG-2 in the mouse GBM tumors, suggesting a minimal contribution of monocytes/macrophages or pericytes to the Tie2+ cell population in the GBM model14. The gene discussed is TEK; the disease is glioblastoma.